Back to results
US 11,932,846 B2Granted
Chloramphenicol resistant split protein and uses thereof
AssigneeTechnology Innovation Momentum Fund (Israel) Limited Partnership
InventorGali Prag
Life of this patent
Estimating the term…
Abstract
A system for expressing a chloramphenicol split protein is disclosed. Uses thereof are also disclosed.
Claims14
A construct system comprising:
- (i) a first nucleic acid construct comprising a first polynucleotide having a nucleic acid sequence that encodes a N-terminal fragment of chloramphenicol acetyl transferase (CAT), said N-terminal fragment comprising a first portion of the catalytic active site of said CAT, said N-terminal fragment being devoid of acetylating activity;
- and
- (ii) a second nucleic acid construct comprising a second polynucleotide having a nucleic acid sequence that encodes a C terminal fragment of said CAT, said C-terminal fragment comprising a second portion of the catalytic active site of said CAT, said C-terminal fragment being devoid of acetylating activity;
- and
- wherein said N-terminal fragment is capable of associating with said C-terminal fragment to generate an active CAT that is capable of acetylating chloramphenicol,
- wherein said N terminal fragment consists of the amino acid sequence as set forth in SEQ ID NO:
- 2 or 6;
- and/or
- said C-terminal fragment consists of the amino acid sequence as set forth in SEQ ID NOs:
- 3 or 7.
7 more elements
Dependencies are inferred from the claim text.